These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 31932581

  • 1. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K/Akt signaling pathway.
    Zhao J, Zhang X, Gao T, Wang S, Hou Y, Yuan P, Yang Y, Yang T, Xing J, Li J, Liu S.
    Cell Death Dis; 2020 Jan 13; 11(1):25. PubMed ID: 31932581
    [Abstract] [Full Text] [Related]

  • 2. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
    Gao T, Zhang X, Zhao J, Zhou F, Wang Y, Zhao Z, Xing J, Chen B, Li J, Liu S.
    Cancer Lett; 2020 Jan 28; 469():89-101. PubMed ID: 31639424
    [Abstract] [Full Text] [Related]

  • 3. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J, Huang Q, Long X, Zhang J, Huang X, Aa J, Yang H, Chen Z, Xing J.
    J Hepatol; 2015 Dec 28; 63(6):1378-89. PubMed ID: 26282231
    [Abstract] [Full Text] [Related]

  • 4. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, Li L, Jia J, Pilo MG, Wang J, Cigliano A, Ma Z, Kuang W, Tang Z, Zhang Z, Shui G, Ribback S, Dombrowski F, Evert M, Pascale RM, Cossu C, Pes GM, Osborne TF, Calvisi DF, Chen X, Chen L.
    Gut; 2020 Jan 28; 69(1):177-186. PubMed ID: 30954949
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway.
    Zhao S, Cheng L, Shi Y, Li J, Yun Q, Yang H.
    Cell Death Dis; 2021 Jan 05; 12(1):18. PubMed ID: 33414447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, Brozzetti S, Staniscia T, Chen X, Dombrowski F, Evert M.
    Gastroenterology; 2011 Mar 05; 140(3):1071-83. PubMed ID: 21147110
    [Abstract] [Full Text] [Related]

  • 9. Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche.
    Miranda F, Mannion D, Liu S, Zheng Y, Mangala LS, Redondo C, Herrero-Gonzalez S, Xu R, Taylor C, Chedom DF, Carrami EM, Albukhari A, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Salah E, Abdul Azeez KR, Elkins JM, Campo L, Myers KA, Klotz D, Bivona S, Dhar S, Bast RC, Saya H, Choi HG, Gray NS, Fischer R, Kessler BM, Yau C, Sood AK, Motohara T, Knapp S, Ahmed AA.
    Cancer Cell; 2016 Aug 08; 30(2):273-289. PubMed ID: 27478041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
    Li X, Chen YT, Josson S, Mukhopadhyay NK, Kim J, Freeman MR, Huang WC.
    PLoS One; 2013 Aug 08; 8(8):e70987. PubMed ID: 23951060
    [Abstract] [Full Text] [Related]

  • 12. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
    Dai XM, Zhang YH, Lin XH, Huang XX, Zhang Y, Xue CR, Chen WN, Ye JX, Lin XJ, Lin X.
    Mol Oncol; 2021 Jan 08; 15(1):228-245. PubMed ID: 33128264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. SIK2: A critical glucolipid metabolic reprogramming regulator and potential target in ovarian cancer.
    Hu D, Du J, Xing Y, Cheng Y, He R, Liang X, Li H, Yang Y.
    J Obstet Gynaecol Res; 2023 Aug 08; 49(8):2000-2009. PubMed ID: 37317594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
    Chu H, Du C, Yang Y, Feng X, Zhu L, Chen J, Yang F.
    Toxins (Basel); 2022 Nov 30; 14(12):. PubMed ID: 36548730
    [Abstract] [Full Text] [Related]

  • 18. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW.
    J Pathol; 2018 Oct 30; 246(2):180-190. PubMed ID: 29968360
    [Abstract] [Full Text] [Related]

  • 19. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K, Wagner R, Varga F, Singer CF, Karlic H, Grunt TW.
    Mol Cancer Res; 2011 Dec 30; 9(12):1767-79. PubMed ID: 21970855
    [Abstract] [Full Text] [Related]

  • 20. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
    Zaidi N, Royaux I, Swinnen JV, Smans K.
    Mol Cancer Ther; 2012 Sep 30; 11(9):1925-35. PubMed ID: 22718913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.